Alyeska Investment Group, L.P. Charles River Laboratories International, Inc. Transaction History

Alyeska Investment Group, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $16.6 Million - $22.7 Million	90,737 Added 37.39%	333,429 $65.6 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $25,720 - $38,102	126 Added 0.05%	242,692 $51.9 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $13.4 Million - $18.9 Million	52,319 Added 27.5%	242,566 $68.9 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $27.9 Million - $35.6 Million	79,335 Added 71.53%	190,247 $71.7 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $18.6 Million - $22.9 Million	49,937 Added 81.9%	110,912 $45.8 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $5.69 Million - $7.18 Million	-19,330 Reduced 24.07%	60,975 $22.6 Million
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $37.6 Million - $60 Million	-316,387 Reduced 79.76%	80,305 $14 Million
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $19.9 Million - $24.1 Million	157,716 Added 66.0%	396,692 $60.6 Million
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $11.6 Million - $13.4 Million	93,093 Added 63.81%	238,976 $31.6 Million
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $3.15 Million - $3.79 Million	-25,505 Reduced 14.88%	145,883 $0
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $36.8 Million - $44.2 Million	-328,488 Reduced 65.71%	171,388 $23.1 Million
Q2 2018 Aug 14, 2018	SELL	$102.37 - $117.25 $12.1 Million - $13.8 Million	-117,928 Reduced 19.09%	499,876 $56.1 Million
Q1 2018 May 15, 2018	BUY	$98.19 - $115.2 $60.7 Million - $71.2 Million	617,804 New	617,804 $65.9 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.